Skip to main content
Premium Trial:

Request an Annual Quote

NeuMoDx Molecular, Sentinel Diagnostics Partner for MDx Development

NEW YORK – NeuMoDx Molecular and Sentinel Diagnostics have formed a partnership to develop new molecular diagnostics assays, the companies announced Monday. The assays will be for the detection and monitoring of post-transplant infections, parasitic and hospital acquired infections, and respiratory infections; and for pharmacogenetics applications, the firms said in a statement.

Ann Arbor, Michigan-based NeuMoDx offers two automated, random-access, sample-to-results molecular diagnostics instruments, the NeuMoDx 96 and 288 Molecular Systems. The firm has been expanding the assay menu for the systems both through internal development and through partnerships, such as with SelfScreen and XCR Diagnostics.

Sentinel Diagnostics, a kit developer based in Milan, Italy, has developed a proprietary chemistry called STAT-NAT to stabilize the PCR mix. The chemistry enables room temperature transport and storage, as well as performance improvement.

Sentinel's qPCR assays will be adapted to the NeuMoDx 96 and 288 Molecular Systems and will incorporate the STAT-NAT technology, the firms said, which will also be specifically optimized for the NeuMoDx Molecular systems.

Financial and other terms of the deal were not disclosed.

NeuMoDx received clearance for its 288 system and an assay for Group B Strep last year, and also has also obtained CE-IVD mark on tests for hepatitis B and C viruses, as well as cytomegalovirus and Epstein-Barr virus.

Sentinel Diagnostics partnered with Ortho Clinical Diagnostics last year for distribution and promotion of Sentinel's C-reactive protein assay. It also offers assay kits for malaria and Leishmaniasis on its website.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.